Amicus Therapeutics (LTS:0HF9) Construction In Progress : $0.0 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Amicus Therapeutics Construction In Progress?

Amicus Therapeutics's quarterly construction in progress increased from Sep. 2024 ($0.0 Mil) to Dec. 2024 ($0.3 Mil) but then declined from Dec. 2024 ($0.3 Mil) to Mar. 2025 ($0.0 Mil).

Amicus Therapeutics's annual construction in progress declined from Dec. 2022 ($4.2 Mil) to Dec. 2023 ($3.8 Mil) and declined from Dec. 2023 ($3.8 Mil) to Dec. 2024 ($0.3 Mil).

Amicus Therapeutics Construction In Progress Historical Data

The historical data trend for Amicus Therapeutics's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amicus Therapeutics Construction In Progress Chart

Amicus Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Construction In Progress

Get a 7-Day Free Trial

5.87

8.23

4.16

3.81

0.26

Amicus Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Construction In Progress	Get a 7-Day Free Trial															-	-	-	0.26	-

Amicus Therapeutics Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Amicus Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amicus Therapeutics Inc (LTS:0HF9) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

FOLD:USA AM6:Germany

Address

47 Hulfish Street, Princeton, NJ, USA, 08542

Website

https://www.amicusrx.com

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Amicus Therapeutics Headlines

No Headlines